Keyphrases
Fetus
100%
Peer Support
50%
Encephalocele
50%
Nasal Encephalocele
50%
Atlanta
50%
Transcytosis
50%
During Pregnancy
50%
Society for Maternal-Fetal Medicine
50%
Flotillin
50%
Obstetric Outcomes
50%
Women with Diabetes
50%
Needs Assessment
50%
Diabetes
50%
Tocolysis
50%
Racial Disparities
50%
Malignant Hypertension
50%
Transethmoidal Encephalocele
50%
Neonatal Outcome
50%
Postpartum Patient
50%
Parturient
50%
Patients with Diabetes
50%
17-hydroxyprogesterone (17-OHP)
50%
17α-hydroxyprogesterone Caproate
50%
Preterm Birth Prevention
50%
Buddy Program
50%
Maternal-fetal Intervention
50%
Human Placenta
50%
Staff Experience
50%
Seizure Disorder
50%
Pregnant Women
50%
COVID-19
50%
Resuscitation
50%
Fetal Myelomeningocele Repair
50%
Peripartum Period
50%
Antepartum
50%
Lactation Support
50%
Inclusion Criteria
50%
Fetal Compromise
50%
Maternal-fetal
50%
Breastfeeding Support
50%
Exclusion Criteria
50%
Preterm Birth
31%
United States
28%
Obstetrics
25%
Low-income Women
25%
Radiologic
25%
Breast Malignancy
25%
Waiting Time
25%
Corticosteroids
25%
Survey-based
25%
Medicine and Dentistry
Diseases
75%
Obstetrics
66%
Perinatology
62%
Encephalocele
50%
Meningomyelocele
50%
Fetal Intervention
50%
Decision Making
50%
Intrapartum
50%
Premature Labor
50%
Peer Group
50%
Malignant Neoplasm
50%
Patient with Diabetes
50%
Malignant Hypertension
50%
Epileptic Seizure
50%
Hydroxyprogesterone Caproate
50%
Ethnic Disparity
50%
Racial Disparity
50%
Diabetes
50%
Needs Assessment
50%
Cancer
50%
Hydroxyprogesterone
50%
Resuscitation
50%
Hypoglycemia
50%
Dysglycemia
50%
Pregnancy
43%
Postprandial Hyperglycemia
41%
Glycemic
41%
Fetal Surveillance
25%
Fetus Electrocardiography
25%
Biophysical Profile
25%
Fetus Death
25%
Early Intervention
25%
Nonstress Test
25%
Exercise Test
25%
Fetus Risk
25%
Breast Melanoma
25%
Hematologic Malignancy
25%
Surgery
25%
Cervix
25%
Chemotherapy
25%
Glucose Transporter 2
25%
Counseling
18%
Insulin Treatment
16%
Pediatric Surgery
12%
Neonatology
12%
Ethnic Groups
12%
Odds Ratio
12%
Clinician
10%
Coordination Compound
8%
Cesarean Section
8%
